XRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
XORTX Therapeutics Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026
$1.01−0.23 (-18.55%)
Close on Oct 19, 2026
XORTX Therapeutics statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | XORTX Therapeutics | Industry median |
|---|---|---|
| Market Cap | C$157.95K | C$123.83M |
| Enterprise Value | C$157.95K | C$93.80M |
Efficiency
| Measure | XORTX Therapeutics | Industry median |
|---|---|---|
| Employee Count | 2 | 26 |
Shares
| Measure | XORTX Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 109,596 | 74,643,400 |
| Shares Change (YoY) | 64.5% | 18.0% |
| Float | 109,596 | 74,292,200 |
| Shares Held by Insiders | 0.00% | 0.00% |
| Shares Held by Institutions | 36.9% | 9.14% |
Calculated by StockData from XORTX Therapeutics's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.